Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Aims to make true end-to-end analysis attainable.
February 23, 2024
By: Charlie Sternberg
Almaden Genomics has partnered with BigOmics Analytics to integrate Omics Playground with g.nome, Almaden’s cloud-native omics data science solution to provide end-to-end analysis. While g.nome is designed to facilitate effortless iteration in data processing and analysis, allowing researchers to explore their results with complete traceability and reproducibility, Omics Playground is a data discovery platform that aims to enable researchers to dig deeper with interactive analysis for a better understanding of underlying biology. “Connecting Omics Playground with the g.nome solution gives researchers an easy transition into downstream analysis,” said David Gascoigne, CEO of Almaden Genomics. “The ability to go further downstream with added tertiary analysis further accelerates the researcher’s race toward critical insights.” Swiss-based BigOmics developed Omics Playground to help scientists explore their omics data with an interactive interface, offering intuitive visualization and data exploration modules. Pairing Omics Playground with g.nome simplifies the journey for the data scientist and biologist wanting to streamline drug discovery. “Linking our platform with g.nome allows us to make true end-to-end analysis attainable,” said Murat Akhmedov, Ph.D., Co-founder and CEO at BigOmics. “We aim to democratize omics data analysis, expediting tertiary analysis and enhancing collaboration within biotech and academic teams. Making tools more accessible invites more innovation from all levels by lowering the barriers to discovery.” Almaden Genomics’ g.nome platform is designed to deliver pre-built, transparent, and fully modifiable workflows that enable scientists to unlock results quickly and easily and dig deeper where needed—with a complete understanding of the results and where they came from.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !